MiR-200b suppresses proliferation of glioma and its stem cells by targeting CD133

Tumor

Volumn 34, Issue 3, 2014, Pages 231-237

  Zhao, Wen Jian ^a   Yang, Liang ^b   He, Han Jiang ^a  

^a XIANGNAN UNIVERSITY   (China)

^b Chenzhou People's Hospital   (China)

Author keywords

Cell invasion assay; Cell proliferation; Glioma; MicroRNAs; Receptors, cell surface

Indexed keywords

CD133 ANTIGEN; LUCIFERASE; MESSENGER RNA; MICRORNA 200B; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL INVASION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOMA CELL; PROTEIN RNA BINDING; PROTEIN TARGETING;

EID: 84896989374     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2014.03.006     Document Type: Article

References (20)

1. Iorio MV, Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer[J]. Cancer Res, 2007, 67(18):8699-8707.
2. Elson-Schwab I, Lorentzen A, Marshall CJ. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion[J]. PLoS One, 2010, 5(10):e13176.
3. Adam L, Zhong M, Choi W, et al. MiR-200 expression regulates epithelial-tomesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy[J]. Clin Cancer Res, 2009, 15(16):5060-5072.
4. Xia W, Li J, Chen L, et al. MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells[J]. Mol Cell Biochem, 2010, 344(1-2):261-266.
5. Wang Z, Zhao Y, Smith E, et al. Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by micoRNA-200b[J]. Toxicol Sci, 2011, 121(1):110-122.
6. Kurashige J, Kamohara H, Watanabe M, et al. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma[J]. Ann Surg Oncol, 2012, 19(Suppl3):S656-664.
7. Stupp R, Mason WP, Van Den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352(10):987-996.
8. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414(6859):105-111.
9. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J]. Nature, 2007, 445(7123):106-110.
10. Wen L, Chen XZ, Yang K, et al. Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review[J]. PLoS One, 2013, 8(3):e59154.
11. Welte Y, Davies C, Schäfer R, et al. Patient derived cell culture and isolation of CD133+ putative cancer stem cells from melanoma[J]. J Vis Exp, 2013, 13 (73):122-124.
12. Arndt K, Grinenko T, Mende N, et al. CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells[J]. Proc Natl Acad Sci U S A, 2013, 110(14):5582-5587.
13. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis[J]. RNA Boil, 2008, 5(3):115-119.
14. Mongroo PS, Rustgi AK. The role of the miR-200 family in epithelial-mesenchymal transition[J]. Cancer Biol Ther, 2010, 10(3):219-222.
15. Du Y, Xu Y, Ding L, et al. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth[J]. J Gastroenterol, 2009, 44(6):556-561.
16. Cochrane DR, Howe EN, Spoelstra NS, et al. Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers[J]. J Oncol, 2010, 2010:821717.
17. Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells[J]. Cell, 2009, 138(3):592-603.
18. Leskelä S, Leandro-García LJ, Mendiola M, et al. The miR-200 family controls beta-tubulin? expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients[J]. Endocr Relat Cancer, 2011, 18(1):85-95.
19. Xia W, Li J, Chen L, et al. MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells[J]. Mol Cell Biochem, 2010, 344(1-2):261-266.
20. Feng B, Wang R, Chen LB. Review of miR-200b and cancer chemosensitivity[J]. Biomed Pharmacother, 2012, 66(6):397-402.